Advances in understanding the pathogenesis of HLH

British Journal of Haematology

Volumn 161, Issue 5, 2013, Pages 609-622

  Usmani, G Naheed ^a   Woda, Bruce A ^b   Newburger, Peter E ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Haemophagocytic syndrome; Immunodeficiency; Macrophages; Mutations; NK cells

Indexed keywords

ANEMIA; AP3B1 GENE; CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TYPE 1; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TYPE 2; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TYPE 3; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TYPE 4; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS TYPE 5; FEVER; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GRISCELLI SYNDROME; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE DEFICIENCY; LIVER DISEASE; LUNG DISEASE; LYMPHOPROLIFERATIVE DISEASE; LYST GENE; MACROPHAGE ACTIVATION SYNDROME; NEUROLOGIC DISEASE; OCULAR ALBINISM; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRF1 GENE; PRIORITY JOURNAL; RAB27A GENE; RETICULOENDOTHELIOSIS; REVIEW; SKIN DISEASE; STX11 GENE; STXBP2 GENE; SYNDROME DELINEATION; THROMBOCYTOPENIA; UNC13D GENE; X LINKED LYMPHOPROLIFERATIVE SYNDROME;

EPSTEIN-BARR VIRUS INFECTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION SYNDROME; MUTATION; NEOPLASMS;

EID: 84877819974     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12293     Document Type: Review

References (131)

1. Abdelhaleem, M., Shago, M., Beimnet, K., Sayeh, E., Bartakke, S. & Weitzman, S. (2007) Childhood acute myeloid leukemia with hemophagocytosis by the blasts and inv (8) (p11q13) with MOZ-TIF2 fusion transcripts. Journal of Pediatric Hematology/Oncology, 29, 643-645.
2. Ahn, J.S., Rew, S.Y., Shin, M.G., Kim, H.R., Yang, D.H., Cho, D., Kim, S.H., Bae, S.Y., Lee, S.R., Kim, Y.K., Kim, H.J. & Lee, J.J. (2010) Clinical significance of clonality and Epstein Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. American Journal of Hematology, 85, 719-722.
3. Allen, C.E., Yu, X., Kozinetz, C.A. & McClain, K.L. (2008) Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 50, 1227-1235.
4. Arico, M., Janka, G., Fischer, A., Henter, J.I., Blanche, S., Elinder, G., Martinetti, M. & Rusca, M.P. (1996) Hemophagocytic lymphohistiocytosis. Report of 122 children from the international registry. FHL study group of the histiocyte society. Leukemia, 10, 197-203.
5. Aslan, D., Sari, S., Derinoz, O. & Dalgic, B. (2006) Griscelli syndrome: description of a case with Rab27A mutation. Pediatric Hematology and Oncology, 23, 255-261.
6. Balamuth, N.J., Nichols, K.E., Paessler, M. & Teachey, D.T. (2007) Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/Oncology, 29, 569-573.
7. Behrens, E.M., Canna, S.W., Slade, K., Rao, S., Kreiger, P.A., Paessler, M., Kambayashi, T. & Koretzky, G.A. (2011) Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. The Journal of Clinical Investigation, 121, 2264-2277.
8. Berrueco, R., Rives, S., Camos, M., Toll, T., Catala, A. & Estella, J. (2010) Syndromic albinism and haemophagocytosis. British Journal of Haematology, 148, 815.
9. Bertaina, C., Bezzio, S. & Riva, C. (2007) Late onset of familial hemophagocytic lymphohistiocytosis. Minerva Pediatrica, 59, 416-417.
10. Beutel, K., Gross-Wieltsch, U., Wiesel, T., Stadt, U.Z., Janka, G. & Wagner, H.J. (2009) Infection of T lymphocytes in Epstein Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-asian origin. Pediatric Blood & Cancer, 53, 184-190.
11. Billiau, A.D., Roskams, T., Van Damme-Lombaerts, R., Matthys, P. & Wouters, C. (2005) Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood, 105, 1648-1651.
12. Bleesing, J., Prada, A., Siegel, D.M., Villanueva, J., Olson, J., Ilowite, N.T., Brunner, H.I., Griffin, T., Graham, T.B., Sherry, D.D., Passo, M.H., Ramanan, A.V., Filipovich, A. & Grom, A.A. (2007) The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis and Rheumatism, 56, 965-971.
13. Booth, C., Gilmour, K.C., Veys, P., Gennery, A.R., Slatter, M.A., Chapel, H., Heath, P.T., Steward, C.G., Smith, O., O'Meara, A., Kerrigan, H., Mahlaoui, N., Cavazzana-Calvo, M., Fischer, A., Moshous, D., Blanche, S., Pachlopnick-Schmid, J., Latour, S., de Saint-Basile, G., Albert, M., Notheis, G., Rieber, N., Strahm, B., Ritterbusch, H., Lankester, A., Hartwig, N.G., Meyts, I., Plebani, A., Soresina, A., Finocchi, A., Pignata, C., Cirillo, E., Bonanomi, S., Peters, C., Kalwak, K., Pasic, S., Sedlacek, P., Jazbec, J., Kanegane, H., Nichols, K.E., Hanson, I.C., Kapoor, N., Haddad, E., Cowan, M., Choo, S., Smart, J., Arkwright, P.D. & Gaspar, H.B. (2011) X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood, 117, 53-62.
14. Bruck, N., Suttorp, M., Kabus, M., Heubner, G., Gahr, M. & Pessler, F. (2011) Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. Journal of Clinical Rheumatology, 17, 23-27.
15. Bryceson, Y.T., Rudd, E., Zheng, C., Edner, J., Ma, D., Wood, S.M., Bechensteen, A.G., Boelens, J.J., Celkan, T., Farah, R.A., Hultenby, K., Winiarski, J., Roche, P.A., Nordenskjold, M., Henter, J.I., Long, E.O. & Ljunggren, H.G. (2007) Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood, 110, 1906-1915.
16. Castillo, L. (2008) High elevated ferritin levels and the diagnosis of HLH/sepsis/SIRS/MODS/MAS. Pediatric Blood & Cancer, 51, 710; author reply 710-1.
17. Cetica, V., Santoro, A., Gilmour, K.C., Sieni, E., Beutel, K., Pende, D., Marcenaro, S., Koch, F., Grieve, S., Wheeler, R., Zhao, F., zur Stadt, U., Griffiths, G.M. & Arico, M. (2010) STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5. Journal of Medical Genetics, 47, 595-600.
18. Chang, T.Y., Jaffray, J., Woda, B., Newburger, P.E. & Usmani, G.N. (2011) Hemophagocytic lymphohistiocytosis with MUNC13-4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemia. Pediatric Blood & Cancer, 56, 856-858.
19. Chen, R.L., Hsu, Y.H., Ueda, I., Imashuku, S., Takeuchi, K., Tu, B.P. & Chuang, S.S. (2007) Cytophagic histiocytic panniculitis with fatal haemophagocytic lymphohistiocytosis in a paediatric patient with perforin gene mutation. Journal of Clinical Pathology, 60, 1168-1169.
20. Chen, J.H., Fleming, M.D., Pinkus, G.S., Pinkus, J.L., Nichols, K.E., Mo, J.Q. & Perez-Atayde, A.R. (2010) Pathology of the liver in familial hemophagocytic lymphohistiocytosis. The American Journal of Surgical Pathology, 34, 852-867.
21. Chia, J., Yeo, K.P., Whisstock, J.C., Dunstone, M.A., Trapani, J.A. & Voskoboinik, I. (2009) Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer. Proceedings of the National Academy of Sciences of the United States of America, 106, 9809-9814.
22. Chuang, H.C., Lay, J.D., Hsieh, W.C., Wang, H.C., Chang, Y., Chuang, S.E. & Su, I.J. (2005) Epstein Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood, 106, 3090-3096.
23. Clementi, R., Locatelli, F., Dupre, L., Garaventa, A., Emmi, L., Bregni, M., Cefalo, G., Moretta, A., Danesino, C., Comis, M., Pession, A., Ramenghi, U., Maccario, R., Arico, M. & Roncarolo, M.G. (2005) A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood, 105, 4424-4428.
24. Cote, M., Menager, M.M., Burgess, A., Mahlaoui, N., Picard, C., Schaffner, C., Al-Manjomi, F., Al-Harbi, M., Alangari, A., Le Deist, F., Gennery, A.R., Prince, N., Cariou, A., Nitschke, P., Blank, U., El-Ghazali, G., Menasche, G., Latour, S., Fischer, A. & de Saint Basile, G. (2009) Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. The Journal of Clinical Investigation, 119, 3765-3773.
25. Creput, C., Galicier, L., Buyse, S. & Azoulay, E. (2008) Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Medicine, 34, 1177-1187.
26. Danhaive, O., Caniglia, M., Devito, R., Piersigilli, F., Corchia, C. & Auriti, C. (2010) Neonatal liver failure and haemophagocytic lymphohistiocytosis caused by a new perforin mutation. Acta Paediatrica (Oslo, Norway: 1992), 99, 778-780.
27. De Armas, R., Sindou, P., Gelot, A., Routon, M.C., Ponsot, G. & Vallat, J.M. (2004) Demyelinating peripheral neuropathy associated with hemophagocytic lymphohistiocytosis. An immuno-electron microscopic study. Acta Neuropathologica, 108, 341-344.
28. Decaminada, N., Cappellini, M., Mortilla, M., Del Giudice, E., Sieni, E., Caselli, D., Arico, M. & Fonda, C. (2010) Familial hemophagocytic lymphohistiocytosis: clinical and neuroradiological findings and review of the literature. Child's Nervous System, 26, 121-127.
29. Deiva, K., Mahlaoui, N., Beaudonnet, F., de Saint Basile, G., Caridade, G., Moshous, D., Mikaeloff, Y., Blanche, S., Fischer, A. & Tardieu, M. (2012) CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology, 78, 1150-1156.
30. Dhote, R., Simon, J., Papo, T., Detournay, B., Sailler, L., Andre, M.H., Dupond, J.L., Larroche, C., Piette, A.M., Mechenstock, D., Ziza, J.M., Arlaud, J., Labussiere, A.S., Desvaux, A., Baty, V., Blanche, P., Schaeffer, A., Piette, J.C., Guillevin, L., Boissonnas, A. & Christoforov, B. (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis and Rheumatism, 49, 633-639.
31. Domachowske, J.B. (2006) Infectious triggers of hemophagocytic syndrome in children. The Pediatric Infectious Disease Journal, 25, 1067-1068.
32. Domenech Abellan, E., Lopez Pino, M.A., Solis Muniz, I. & Garcia Esparza, E. (2010) Familial hemophagocytic lymphohistiocytosis: neuroradiological findings. Radiologia, 52, 76-80.
33. Egeler, R.M., Shapiro, R., Loechelt, B. & Filipovich, A. (1996) Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/Oncology, 18, 340-345.
34. Enders, A., Zieger, B., Schwarz, K., Yoshimi, A., Speckmann, C., Knoepfle, E.M., Kontny, U., Muller, C., Nurden, A., Rohr, J., Henschen, M., Pannicke, U., Niemeyer, C., Nurden, P. & Ehl, S. (2006) Lethal hemophagocytic lymphohistiocytosis in hermansky-pudlak syndrome type II. Blood, 108, 81-87.
35. Fall, N., Barnes, M., Thornton, S., Luyrink, L., Olson, J., Ilowite, N.T., Gottlieb, B.S., Griffin, T., Sherry, D.D., Thompson, S., Glass, D.N., Colbert, R.A. & Grom, A.A. (2007) Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis & Rheumatism, 56, 3793-3804.
36. Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., Lambert, N., Ouachée-Chardin, M., Chedeville, G., Tamary, H., Minard-Colin, V., Vilmer, E., Blanche, S., Le Deist, F., Fischer, A. & de Saint Basile, G. (2003) Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell, 115, 461-473.
37. Fitzgerald, N.E. & MacClain, K.L. (2003) Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatric Radiology, 33, 392-401.
38. Gerritsen, A., Lam, K., Marion Schneider, E. & van den Heuvel-Eibrink, M.M. (2006) An exclusive case of juvenile myelomonocytic leukemia in association with kikuchi's disease and hemophagocytic lymphohistiocytosis and a review of the literature. Leukemia Research, 30, 1299-1303.
39. Goel, S., Polski, J.M. & Imran, H. (2012) Sensitivity and specificity of bone marrow hemophagocytosis in hemophagocytic lymphohistiocytosis. Annals of Clinical and Laboratory Science, 42, 21-25.
40. Goo, H.W. & Weon, Y.C. (2007) A spectrum of neuroradiological findings in children with haemophagocytic lymphohistiocytosis. Pediatric Radiology, 37, 1110-1117.
41. Grom, A.A., Villanueva, J., Lee, S., Goldmuntz, E.A., Passo, M.H. & Filipovich, A. (2003) Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. The Journal of Pediatrics, 142, 292-296.
42. Gupta, A., Tyrrell, P., Valani, R., Benseler, S., Weitzman, S. & Abdelhaleem, M. (2008) The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 51, 402-404.
43. Gupta, A.A., Tyrrell, P., Valani, R., Benseler, S., Abdelhaleem, M. & Weitzman, S. (2009) Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. Journal of Pediatric Hematology/Oncology, 31, 81-84.
44. Han, A.R., Lee, H.R., Park, B.B., Hwang, I.G., Park, S., Lee, S.C., Kim, K., Lim, H.Y., Ko, Y.H., Kim, S.H. & Kim, W.S. (2007) Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Annals of Hematology, 86, 493-498.
45. Hendricks, M., Pillay, S., Davidson, A., De Decker, R. & Lawrenson, J. (2010) Kawasaki disease preceding haemophagocytic lymphohistiocytosis: challenges for developing world practitioners. Pediatric Blood & Cancer, 54, 1023-1025.
46. Henter, J.I. (2002) Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Medical and Pediatric Oncology, 38, 305-309.
47. Henter, J.I. (2008) Pronounced hyperferritinemia: expanding the field of hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 50, 1127-1129.
48. Henter, J.I., Elinder, G., Soder, O., Hansson, M., Andersson, B. & Andersson, U. (1991) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood, 78, 2918-2922.
49. Henter, J., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J. & Janka, G. (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131.
50. Henzan, T., Nagafuji, K., Tsukamoto, H., Miyamoto, T., Gondo, H., Imashuku, S. & Harada, M. (2006) Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. American Journal of Hematology, 81, 59-61.
51. Horne, A., Ramme, K.G., Rudd, E., Zheng, C., Wali, Y., al-Lamki, Z., Gurgey, A., Yalman, N., Nordenskjold, M. & Henter, J.I. (2008a) Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis. British Journal of Haematology, 143, 75-83.
52. Horne, A., Trottestam, H., Arico, M., Egeler, R.M., Filipovich, A.H., Gadner, H., Imashuku, S., Ladisch, S., Webb, D., Janka, G., Henter, J.I. & Histiocyte Society. (2008b) Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. British Journal of Haematology, 140, 327-335.
53. Imashuku, S. (2007) Systemic type Epstein Barr virus-related lymphoproliferative diseases in children and young adults: challenges for pediatric hemato-oncologists and infectious disease specialists. Pediatric Hematology and Oncology, 24, 563-568.
54. Imashuku, S., Kitazawa, K., Ishii, M., Kataoka, S., Asami, K., Ishii, E., Fukushima, K., Sako, M., Matsubayashi, T., Teramura, G.T. & Hibi, S. (2000) Bone marrow changes mimicking myelodysplasia in patients with hemophagocytic lymphohistiocytosis. International Journal of Hematology, 72, 353-357.
55. Ishii, E., Ueda, I., Shirakawa, R., Yamamoto, K., Horiuchi, H., Ohga, S., Furuno, K., Morimoto, A., Imayoshi, M., Ogata, Y., Zaitsu, M., Sako, M., Koike, K., Sakata, A., Takada, H., Hara, T., Imashuku, S., Sasazuki, T. & Yasukawa, M. (2005) Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood, 105, 3442-3448.
56. Ishii, E., Ohga, S., Imashuku, S., Yasukawa, M., Tsuda, H., Miura, I., Yamamoto, K., Horiuchi, H., Takada, K., Ohshima, K., Nakamura, S., Kinukawa, N., Oshimi, K. & Kawa, K. (2007) Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. International Journal of Hematology, 86, 58-65.
57. Janka, G.E. (2012) Familial and acquired hemophagocytic lymphohistiocytosis. Annual Review of Medicine, 63, 233-246.
58. Jordan, M.B. & Filipovich, A.H. (2008) Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplantation, 42, 433-437.
59. Jordan, M.B., Hildeman, D., Kappler, J. & Marrack, P. (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood, 104, 735-743.
60. Jordan, M.B., Allen, C.E., Weitzman, S., Filipovich, A.H. & McClain, K.L. (2011) How I treat hemophagocytic lymphohistiocytosis. Blood, 118, 4041-4052.
61. Kapelari, K., Fruehwirth, M., Heitger, A., Konigsrainer, A., Margreiter, R., Simma, B. & Offner, F.A. (2005) Loss of intrahepatic bile ducts: an important feature of familial hemophagocytic lymphohistiocytosis. Virchows Archiv, 446, 619-625.
62. Kasahara, Y., Yachie, A., Takei, K., Kanegane, C., Okada, K., Ohta, K., Seki, H., Igarashi, N., Maruhashi, K., Katayama, K., Katoh, E., Terao, G., Sakiyama, Y. & Koizumi, S. (2001) Differential cellular targets of Epstein Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood, 98, 1882-1888.
63. Kashiwagi, Y., Kawashima, H., Sato, S., Ioi, H., Amaha, M., Takekuma, K., Hoshika, A., Oshiro, H., Matsubayashi, J. & Mukai, K. (2007) Virological and immunological characteristics of fatal virus-associated haemophagocytic syndrome (VAHS). Microbiology and Immunology, 51, 53-62.
64. Kaya, Z., Ehl, S., Albayrak, M., Maul-Pavicic, A., Schwarz, K., Kocak, U., Ergun, M.A. & Gursel, T. (2011) A novel single point mutation of the LYST gene in two siblings with different phenotypic features of chediak higashi syndrome. Pediatric Blood & Cancer, 56, 1136-1139.
65. Keith, M.P., Pitchford, C. & Bernstein, W.B. (2012) Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus. Journal of Clinical Rheumatology, 18, 134-137.
66. Kelly, A. & Ramanan, A.V. (2007) Recognition and management of macrophage activation syndrome in juvenile arthritis. Current Opinion in Rheumatology, 19, 477-481.
67. Kerzel, S., Zemlin, M., Komhoff, M., Klaus, G. & Maier, R.F. (2009) Hyperferritinemia as the diagnostic clue in life-threatening hemophagocytic lymphohistiocytosis. Klinische Padiatrie, 221, 318-321.
68. Kim, H.K., Kim, H.G., Cho, S.J., Hong, Y.M., Sohn, S., Yoo, E.S., Chung, W.S. & Ryu, K.H. (2011) Clinical characteristics of hemophagocytic lymphohistiocytosis related to Kawasaki disease. Pediatric Hematology and Oncology, 28, 230-236.
69. Kogawa, K., Lee, S.M., Villanueva, J., Marmer, D., Sumegi, J. & Filipovich, A.H. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood, 99, 61-66.
70. Kuwata, K., Yamada, S., Kinuwaki, E., Naito, M. & Mitsuya, H. (2006) Peripheral hemophagocytosis: an early indicator of advanced systemic inflammatory response syndrome/hemophagocytic syndrome. Shock (Augusta, Ga.), 25, 344-350.
71. Lee, H.Y., Huang, Y.C., Lin, T.Y., Huang, J.L., Yang, C.P., Hsueh, T., Wu, C.T. & Hsia, S.H. (2010) Primary Epstein Barr virus infection associated with kikuchi's disease and hemophagocytic lymphohistiocytosis: a case report and review of the literature. Journal of Microbiology, Immunology, and Infection, 43, 253-257.
72. Lim, G.Y., Cho, B. & Chung, N.G. (2008) Hemophagocytic lymphohistiocytosis preceded by kikuchi disease in children. Pediatric Radiology, 38, 756-761.
73. Lin, Y.W., Horiuchi, H., Ueda, I. & Nambu, M. (2007) Recurrent hemophagocytic lymphohistiocytosis accompanied by kikuchi's disease. Leukemia & Lymphoma, 48, 2447-2451.
74. Lin, C.I., Yu, H.H., Lee, J.H., Wang, L.C., Lin, Y.T., Yang, Y.H. & Chiang, B.L. (2012) Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clinical Rheumatology, 31, 1223-1230.
75. Lopez-Alvarez, M.R., Martinez-Sanchez, M.V., Salgado-Cecilia, M.G., Campillo, J.A., Heine-Suner, D., Villar-Permuy, F., Fuster, J.L., Bas, A., Gil-Herrera, J., Muro, M., Garcia-Alonso, A.M., Alvarez-Lopez, M.R. & Minguela, A. (2009) Association of monoclonal expansion of Epstein Barr virus-negative CD158a+ NK cells secreting large amounts of gamma interferon with hemophagocytic lymphohistiocytosis. Clinical and Vaccine Immunology, 16, 142-145.
76. Lu, G., Xie, Z.D., Shen, K.L., Ye, L.J., Wu, R.H., Liu, C.Y., Jin, Y.K. & Yang, S. (2009) Mutations in the perforin gene in children with hemophagocytic lymphohistiocytosis. Chinese Medical Journal, 122, 2851-2855.
77. Lykens, J.E., Terrell, C.E., Zoller, E.E., Risma, K. & Jordan, M.B. (2011) Perforin is a critical physiologic regulator of T-cell activation. Blood, 118, 618-626.
78. Maakaroun, N.R., Moanna, A., Jacob, J.T. & Albrecht, H. (2010) Viral infections associated with haemophagocytic syndrome. Reviews in Medical Virology, 20, 93-105.
79. Macartney, C.A., Weitzman, S., Wood, S.M., Bansal, D., Steele, M., Meeths, M., Abdelhaleem, M. & Bryceson, Y.T. (2011) Unusual functional manifestations of a novel STX11 frameshift mutation in two infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4). Pediatric Blood & Cancer, 56, 654-657.
80. Makay, B., Yilmaz, S., Turkyilmaz, Z., Unal, N., Oren, H. & Unsal, E. (2008) Etanercept for therapy-resistant macrophage activation syndrome. Pediatric Blood & Cancer, 50, 419-421.
81. Malhotra, A.K., Bhaskar, G., Nanda, M., Kabra, M., Singh, M.K. & Ramam, M. (2006) Griscelli syndrome. Journal of the American Academy of Dermatology, 55, 337-340.
82. Meeths, M., Bryceson, Y.T., Rudd, E., Zheng, C., Wood, S.M., Ramme, K., Beutel, K., Hasle, H., Heilmann, C., Hultenby, K., Ljunggren, H.G., Fadeel, B., Nordenskjold, M. & Henter, J.I. (2010) Clinical presentation of griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatric Blood & Cancer, 54, 563-572.
83. Mehta, P.A., Davies, S.M., Kumar, A., Devidas, M., Lee, S., Zamzow, T., Elliott, J., Villanueva, J., Pullen, J., Zewge, Y., Filipovich, A. & Children's Oncology Group. (2006) Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the children's oncology group. Leukemia, 20, 1539-1541.
84. Morrell, D., Pepping, M., Scott, J., Esterly, N. & Drolet, B. (2002) Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Archives of Dermatology, 138, 1208.
85. Nagafuji, K., Nonami, A., Kumano, T., Kikushige, Y., Yoshimoto, G., Takenaka, K., Shimoda, K., Ohga, S., Yasukawa, M., Horiuchi, H., Ishii, E. & Harada, M. (2007) Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica, 92, 978-981.
86. Ohadi, M., Lalloz, M.R., Sham, P., Zhao, J., Dearlove, A.M., Shiach, C., Kinsey, S., Rhodes, M. & Layton, D.M. (1999) Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. American Journal of Human Genetics, 64, 165-171.
87. Pachlopnik Schmid, J., Canioni, D., Moshous, D., Touzot, F., Mahlaoui, N., Hauck, F., Kanegane, H., Lopez-Granados, E., Mejstrikova, E., Pellier, I., Galicier, L., Galambrun, C., Barlogis, V., Bordigoni, P., Fourmaintraux, A., Hamidou, M., Dabadie, A., Le Deist, F., Haerynck, F., Ouachee-Chardin, M., Rohrlich, P., Stephan, J.L., Lenoir, C., Rigaud, S., Lambert, N., Milili, M., Schiff, C., Chapel, H., Picard, C., de Saint Basile, G., Blanche, S., Fischer, A. & Latour, S. (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood, 117, 1522-1529.
88. Palazzi, D.L., McClain, K.L. & Kaplan, S.L. (2003) Hemophagocytic syndrome after kawasaki disease. The Pediatric Infectious Disease Journal, 22, 663-666.
89. Ramanan, A.V. & Schneider, R. (2003) Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. The Journal of Rheumatology, 30, 401-403.
90. Ravelli, A., Grom, A.A., Behrens, E.M. & Cron, R.Q. (2012) Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes and Immunity, 13, 289-298.
91. Risdall, R.J., McKenna, R.W., Nesbit, M.E., Krivit, W., Balfour, H.H., Simmons, R.L. & Brunning, R.D. (1979) Virus-associated hemophagocytic syndrome A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer, 44, 993-1002.
92. Risma, K.A., Frayer, R.W., Filipovich, A.H. & Sumegi, J. (2006) Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. The Journal of Clinical Investigation, 116, 182-192.
93. Rudd, E., Goransdotter Ericson, K., Zheng, C., Uysal, Z., Ozkan, A., Gurgey, A., Fadeel, B., Nordenskjold, M. & Henter, J.I. (2006) Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies. Journal of Medical Genetics, 43, e14.
94. Rudd, E., Bryceson, Y.T., Zheng, C., Edner, J., Wood, S.M., Ramme, K., Gavhed, S., Gurgey, A., Hellebostad, M., Bechensteen, A.G., Ljunggren, H.G., Fadeel, B., Nordenskjold, M. & Henter, J.I. (2008) Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 45, 134-141.
95. Ruperto, N., Brunner, H.I., Quartier, P., Constantin, T., Wulffraat, N., Horneff, G., Brik, R., McCann, L., Kasapcopur, O., Rutkowska-Sak, L., Schneider, R., Berkun, Y., Calvo, I., Erguven, M., Goffin, L., Hofer, M., Kallinich, T., Oliveira, S.K., Uziel, Y., Viola, S., Nistala, K., Wouters, C., Cimaz, R., Ferrandiz, M.A., Flato, B., Gamir, M.L., Kone-Paut, I., Grom, A., Magnusson, B., Ozen, S., Sztajnbok, F., Lheritier, K., Abrams, K., Kim, D., Martini, A. & Lovell, D.J. (2012) Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. New England Journal of Medicine, 367, 2396-2406.
96. de Saint Basile, G., Menasche, G. & Latour, S. (2011) Inherited defects causing hemophagocytic lymphohistiocytic syndrome. Annals of the New York Academy of Sciences, 1246, 64-76.
97. Santoro, A., Cannella, S., Trizzino, A., Lo Nigro, L., Corsello, G. & Arico, M. (2005) A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica, 90, 697-698.
98. Santoro, A., Cannella, S., Bossi, G., Gallo, F., Trizzino, A., Pende, D., Dieli, F., Bruno, G., Stinchcombe, J.C., Micalizzi, C., De Fusco, C., Danesino, C., Moretta, L., Notarangelo, L.D., Griffiths, G.M. & Arico, M. (2006) Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 43, 953-960.
99. Schneider, E.M., Lorenz, I., Muller-Rosenberger, M., Steinbach, G., Kron, M. & Janka-Schaub, G.E. (2002) Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood, 100, 2891-2898.
100. Scott, R.B. & Robb-Smith, A.H.T. (1939) Histiocytic medullary reticulosis. Lancet, 2, 194-198.
101. Shamsian, B.S., Gharib, A., Rezaei, N., Esfahani, S.A., Alavi, S., Goudarzipour, K. & Arzanian, M.T. (2010) Development of secondary T-cell acute lymphoblastic leukemia in a child with hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 55, 725-726.
102. Shimada, A., Kato, M., Tamura, K., Hirato, J., Kanegane, H., Takechi, Y., Park, M.J., Sotomatsu, M., Hatakeyama, S. & Hayashi, Y. (2008) Hemophagocytic lymphohistiocytosis associated with uncontrolled inflammatory cytokinemia and chemokinemia was caused by systemic anaplastic large cell lymphoma: a case report and review of the literature. Journal of Pediatric Hematology/Oncology, 30, 785-787.
103. Simonini, G., Pagnini, I., Innocenti, L., Calabri, G.B., De Martino, M. & Cimaz, R. (2010) Macrophage activation syndrome/hemophagocytic lymphohistiocytosis and kawasaki disease. Pediatric Blood & Cancer, 55, 592.
104. Stabile, A., Bertoni, B., Ansuini, V., La Torraca, I., Salli, A. & Rigante, D. (2006) The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. European Review for Medical and Pharmacological Sciences, 10, 53-59.
105. zur Stadt, U., Schmidt, S., Kasper, B., Beutel, K., Diler, A.S., Henter, J., Kabisch, H., Schneppenheim, R., Nürnberg, P., Janka, G. & Hennies, H.C. (2005) Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Human Molecular Genetics, 14, 827-834.
106. zur Stadt, U., Beutel, K., Kolberg, S., Schneppenheim, R., Kabisch, H., Janka, G. & Hennies, H.C. (2006) Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC-13D STX11, and RAB27A. Human Mutation, 27, 62-68.
107. zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., Strauss, J., Kasper, B., Nurnberg, G., Becker, C., Maul-Pavicic, A., Beutel, K., Janka, G., Griffiths, G., Ehl, S. & Hennies, H.C. (2009) Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. American Journal of Human Genetics, 85, 482-492.
108. Stepp, S.E. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (New York, N.Y.), 286, 1957-1959.
109. Sumegi, J., Barnes, M.G., Nestheide, S.V., Molleran-Lee, S., Villanueva, J., Zhang, K., Risma, K.A., Grom, A.A. & Filipovich, A.H. (2011) Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis. Blood, 117, e151-e160.
110. Sumegi, J., Nestheide, S.V., Barnes, M.G., Villanueva, J., Zhang, K., Grom, A.A. & Filipovich, A.H. (2012) Gene expression signatures differ between different clinical forms of familial hemophagocytic lymphohistiocytosis. Blood, 121, e14-24.
111. Tabata, Y., Villanueva, J., Lee, S.M., Zhang, K., Kanegane, H., Miyawaki, T., Sumegi, J. & Filipovich, A.H. (2005) Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood, 105, 3066-3071.
112. Tadmor, T., Vadazs, Z., Dar, H., Laor, R. & Attias, D. (2006) Hemophagocytic syndrome preceding acute myeloid leukemia with der t [7:17] [q12; q11], monosomy, 17 and 5p-. Journal of Pediatric Hematology/Oncology, 28, 544-546.
113. Takada, H., Ohga, S., Mizuno, Y., Nomura, A. & Hara, T. (2004) Increased IL-16 levels in hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/Oncology, 26, 567-573.
114. Tamura, K., Kanazawa, T., Tsukada, S., Kobayashi, T., Kawamura, M. & Morikawa, A. (2008) Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 51, 662-668.
115. Teramura, T., Tabata, Y., Yagi, T., Morimoto, A., Hibi, S. & Imashuku, S. (2002) Quantitative analysis of cell-free Epstein Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leukemia & Lymphoma, 43, 173-179.
116. Toga, A., Wada, T., Sakakibara, Y., Mase, S., Araki, R., Tone, Y., Toma, T., Kurokawa, T., Yanagisawa, R., Tamura, K., Nishida, N., Taneichi, H., Kanegane, H. & Yachie, A. (2010) Clinical significance of cloned expansion and CD5 down-regulation in Epstein Barr virus (EBV)-infected CD8 + T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. The Journal of Infectious Diseases, 201, 1923-1932.
117. Trizzino, A., zur Stadt, U., Ueda, I., Risma, K., Janka, G., Ishii, E., Beutel, K., Sumegi, J., Cannella, S., Pende, D., Mian, A., Henter, J.I., Griffiths, G., Santoro, A., Filipovich, A., Arico, M. & Histiocyte Society HLH Study group. (2008) Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations. Journal of Medical Genetics, 45, 15-21.
118. Ueda, I., Ishii, E., Morimoto, A., Ohga, S., Sako, M. & Imashuku, S. (2006) Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL). Pediatric Blood & Cancer, 46, 482-488.
119. Ueda, I., Kurokawa, Y., Koike, K., Ito, S., Sakata, A., Matsumora, T., Fukushima, T., Morimoto, A., Ishii, E. & Imashuku, S. (2007) Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. American Journal of Hematology, 82, 427-432.
120. Villanueva, J., Lee, S., Giannini, E.H., Graham, T.B., Passo, M.H., Filipovich, A. & Grom, A.A. (2005) Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Research & Therapy, 7, R30-R37.
121. Voskoboinik, I., Smyth, M.J. & Trapani, J.A. (2006) Perforin-mediated target-cell death and immune homeostasis. Nature Reviews Immunology, 6, 940-952.
122. Weisfeld-Adams, J.D., Frank, Y., Havalad, V., Hojsak, J.M., Posada, R., Kaicker, S.M. & Wistinghausen, B. (2009) Diagnostic challenges in a child with familial hemophagocytic lymphohistiocytosis type 3 (FHLH3) presenting with fulminant neurological disease. Child's Nervous System, 25, 153-159.
123. Wood, S.M., Meeths, M., Chiang, S.C., Bechensteen, A.G., Boelens, J.J., Heilmann, C., Horiuchi, H., Rosthoj, S., Rutynowska, O., Winiarski, J., Stow, J.L., Nordenskjold, M., Henter, J.I., Ljunggren, H.G. & Bryceson, Y.T. (2009) Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Blood, 114, 4117-4127.
124. Yanagimachi, M., Naruto, T., Miyamae, T., Hara, T., Kikuchi, M., Hara, R., Imagawa, T., Mori, M., Sato, H., Goto, H. & Yokota, S. (2011a) Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. The Journal of Rheumatology, 38, 769-774.
125. Yanagimachi, M., Goto, H., Miyamae, T., Kadota, K., Imagawa, T., Mori, M., Sato, H., Yanagisawa, R., Kaneko, T., Morita, S., Ishii, E. & Yokota, S. (2011b) Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children. Journal of Clinical Immunology, 31, 946-951.
126. Yang, X., Wada, T., Imadome, K., Nishida, N., Mukai, T., Fujiwara, M., Kawashima, H., Kato, F., Fujiwara, S., Yachie, A., Zhao, X., Miyawaki, T. & Kanegane, H. (2012) Characterization of Epstein Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2. Herpesviridae, 3, 1.
127. Yokota, S., Tanaka, T. & Kishimoto, T. (2012) Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis. Therapeutic Advances in Musculoskeletal Disease, 4, 387-397.
128. Yoshiyama, M., Kounami, S., Nakayama, K., Okutani, T., Aoyagi, N. & Yoshikawa, N. (2010) Cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms in Japanese children with infection-associated hemophagocytic lymphohistiocytosis. Acta Haematologica, 123, 186-190.
129. Zhang, K., Biroschak, J., Glass, D.N., Thompson, S.D., Finkel, T., Passo, M.H., Binstadt, B.A., Filipovich, A. & Grom, A.A. (2008a) Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis and Rheumatism, 58, 2892-2896.
130. Zhang, S., Ma, D., Wang, X., Celkan, T., Nordenskjold, M., Henter, J.I., Fadeel, B. & Zheng, C. (2008b) Syntaxin-11 is expressed in primary human monocytes/macrophages and acts as a negative regulator of macrophage engulfment of apoptotic cells and IgG-opsonized target cells. British Journal of Haematology, 142, 469-479.
131. Zhang, K., Jordan, M.B., Marsh, R.A., Johnson, J.A., Kissell, D., Meller, J., Villanueva, J., Risma, K.A., Wei, Q., Klein, P.S. & Filipovich, A.H. (2011) Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood, 118, 5794-5798.